Wedgewood Pharmacy - Home




Acepromazine Maleate
Acetyl-D-Glucosamine
ACTH (Corticotrophin LA Gel)
Antibiotic-Impregnated Plaster of Paris
Apomorphine
Azathioprine
Azithromycin
Budesonide
Calcium Aluminosilicate
Chlorambucil
Cidofovir Ophthalmic
Cacodylate
Carbazochrome Salicylate
Chlor w/Squalene
Cisapride
Clarithromycin/Rifampin
Cyclophosphamide
Cyclosporine
Cyproheptadine
DCA-700
Demecarium Bromide
Dexamethasone SP
Dantrolene Sodium
Dexamethasone-21-Isonicotinate
Diazepam
Diethylstilbestrol (DES)
Digoxin
Diphenhydramine
Dipyrone
EES/Rifampin
Enrofloxacin
EPM
Estradiol Cypionate
Estrone
Flavor
Flunixin Meglumine
Fluoxetine
Folic Acid
Gabapentin
Griseofulvin
Guaifenesin
Heparin Sodium
Hydroxyzine HCL
Idoxuridine
Interferon Alpha-2B
Iodine
Itraconazole
Ketoprofen
Lomustine
Meclofenamate
Medroxyprogesterone
Methimazole
Methocarbamol
Metoclopramide
Metronidazole
Mitotane
Ophthalmics
P&E
Pentosan Polysulfate
Pentoxifylline
Pergolide
Phenoxybenzamine
Phenylbutazone
Phenylpropanolamine
Piroxicam
Potassium Bromide
Prednisone
Progesterone in Oil
Protamine Zinc Insulin (PZI)
Reserpine

Sucralfate
Tacrolimus
Toltrazuril
Transdermals
Trichlormethiazide/Dexamethasone
Trilostane
Tripelennamine HCl


To prescribe CALL
888-678-1967
hours of operation >>


Enrofloxacin for Veterinary Use
By Barbara Forney VMD

 
Overview
Therapeutic Class
Fluoroquinolone antibiotic
Species
Dogs, Cats, and Horses
Commonly prescribed by vets for:
Susceptible bacterial infection
   

Basic Information

Enrofloxacin is a broad spectrum bactericidal antibiotic. Although the mechanism of action is not well understood, Enrofloxacin is effective against a broad spectrum of gram positive and gram negative bacteria including most species of the following: Pseudomonas aeruginosa, Klebsiella, E.coli., Enterobacter, Campylobacter, Shigella, Salmonella, Aeromonas, Haemophillus, Proteus, Yersinia, Serratia, Vibrio, Brucella, Chlamydia, Staphylocci (including some methicillin resistant strains), Mycoplasma, and Mycobacterium. It is not effective against anaerobic bacteria, and may be variably effective against Streptococcus infections. Enrofloxacin has a similar spectrum of activity as ciprofloxacin but enrofloxacin has been shown to have better bioavailability. With the exception of cerebral spinal fluid, enrofloxacin attains therapeutic levels in most tissues of the body. This makes it a very attractive antibiotic choice for difficult to treat infections, particularly those that need long term antibiotics. Some examples might be osteomyelitis, sinus infections, otitis, difficult soft tissue infections, peritonitis, and pleuritis or pneumonia.

Enrofloxacin is eliminated by both renal and hepatic metabolism. Animals with impaired kidney or liver function may need extra monitoring and dose adjustments to prevent excess drug accumulation.

Dogs and Cats

Enrofloxacin is approved for use in dogs and cats. In dogs it may be given orally, intramuscularly or intra-venously. It is only approved for oral use in cats although there is published information regarding intra muscular use. One of the positive features of enrofloxacin is that it is well absorbed orally and in many cases may be given once a day.

Fluroquinolones including enrofloxacin have been shown to cause articular cartilage abnormalities when the drug is given at high dose levels. The age and breed of the patient should be considered when using enrofloxacin. Large and giant breeds may be more at risk because of a longer period of growth. Enrofloxacin has been shown to be safe in pregnant dogs and lactating dogs, however because of the problems with articular cartilage it should be avoided unless the benefits clearly outweigh the risk to the puppies. This work has not been repeated in cats.

Horses

Enrofloxacin is well absorbed orally and intravenously. It is generally not used intramuscularly because it is too irritating. Although studies have not been done in the horse, there is the risk of developmental cartilage abnormalities with the fluorquinolone antibiotics. Since horses are expected to be athletes, the use of enrofloxacin in the young horse should be carefully weighed against the potential risk of cartilage abnormality.

Side Effects

• Enrofloxacin and the other fluroquinolone antibiotics can cause developmental cartilage abnormalities. As a consequence most veterinarians try to avoid these drugs in young animals.

• Dogs: GI side effects including vomiting, diarrhea, and elevated liver enzymes; Rare CNS signs including ataxia seizures, depression, and anxiety.

• Cats: GI side effects include vomiting, diarrhea, anorexia, elevated liver enzymes. CNS signs include ataxia, seizures, depression; vocalization, and aggression. Rare ocular toxicity may occur.

• Horses: When injectable enrofloxacin is given orally, it can cause mucous membrane irritation, redness, slobbering and swelling.


Precautions

• Animals with severe kidney or liver problems may need a reduced dose of enrofloxacin. Hydration should be monitored and fluid therapy used in animals at risk for dehydration.

• Enrofloxacin should be used with caution or avoided in animals at risk for seizures. This drug is not used in humans due to central nervous system stimulation.

• Enrofloxacin should not be used for regional antibiotic perfusion because it is too irritating and will cause vasculitis.


Drug Interactions

• Sucralfate and some antacids may interfere with the absorption of enrofloxacin. These drugs should be administered two hours apart.

• Enrofloxacin may be used with aminoglycosides, some cephalosporins, and some penicillins in infections where it is warranted based on bacterial sensitivity.

• Enrofloxacin should not be used with nitrofurantoin, chloramphenicol or rifampin.

• Probenicid blocks the renal excretion of enrofloxacin.

• Enrofloxacin interferes with the metabolism of the bronchodilators theophylline and aminophylline. If these drugs are to be used at the same time, blood levels should be monitored.


Overdose

• A single overdose is unlikely to cause toxicity. In dogs given ten times the normal dose over a period of two weeks, adverse effects were limited to loss of appetite and vomiting.


About the Author

Dr. Barbara Forney is a veterinary practitioner in Chester County, Pennsylvania. She has a master's degree in animal science from the University of Delaware and graduated from the University of Pennsylvania School of Veterinary Medicine in 1982.

She began to develop her interest in client education and medical writing 1997. Recent publications include portions of The Pill Book Guide to Medication for Your Dog and Cat, and most recently Understanding Equine Medications published by the Bloodhorse.

Dr. Forney is an FEI veterinarian and an active member of the AAEP, AVMA, and AMWA.

You can purchase books by Dr. Forney at www.exclusivelyequine.com

The information contained on this site is general in nature and is intended for use as an informational aid. It does not cover all possible uses, actions, precautions, side effects, or interactions of the products shown, nor is the information intended as medical advice or diagnosis for individual health problems or for making an evaluation as to the risks and benefits of using a particular product. You should consult your doctor about diagnosis and treatment of any health problems. Information and statements have not been evaluated by the Food and Drug Administration ("FDA"), nor has the FDA approved the products to diagnose, cure or prevent disease.

Wedgewood compounded veterinary medicines are not intended for use in food and food-producing animals.

Request a Brochure | Request a Formulation Consultation


Compound Medications | Veterinary Medicine | Compounding Pharmacy | Veterinary Medications
Information on Expired Medications | Sitemap

Featured Medication: Avastin, Naltrexone, Hydroxyprogesterone, Tri-Mix

Featured Monographs: Metronidazole, Pentosan, Methimazole

Wedgewood Pharmacy
405 Heron Drive Suite 200 • Swedesboro, NJ 08085-1749 • 1-888-678-1967
Copyright © 2004-2008 Wedgewood Village Pharmacy, Inc. All rights reserved.